Business
Significant Collaboration
Significant Collaboration.
About this update from Sareum Holdings Plc
[{"type":"text","content":"\n Sareum Holdings PLC\n09 October 2006\n\n\nFor immediate release 9 October 2006\n\n\n\n SAREUM HOLDINGS PLC\n\n (\"Sareum\" or \"the Company\")\n\n\n\n Research Collaboration with PIramed Ltd\n\nSareum Holdings plc (AIM: SAR), the specialist structure-based drug discovery\nbusiness, is pleased to announce today that it has entered into a significant\nresearch collaboration with PIramed Ltd, a privately owned UK biotechnology\ncompany, to discover novel, targeted drug therapies for the treatment of immune\ninflammatory diseases.\n\nUnder the terms of this collaboration, which is scheduled to run for a period of\nup to 18 months, Sareum will provide multi-disciplinary research teams with the\naim of generating novel drug lead series for further development by PIramed.\nThis involves the generation of novel chemical material using Template\nScreening, Sareum's innovative fragment-based drug discovery technology, and\noptimisation into drug leads using Sareum's automated medicinal chemistry\nplatform.\n\nIn return, Sareum will receive undisclosed research fees and success milestone\npayments, including additional milestone payments if compounds arising out of\nthe collaboration advance to clinical development.\n\nThis is the third multi-disciplinary drug discovery collaboration Sareum has\nsigned this year. Sareum announced agreements of similar scope with Organon and\nIdenix in January and February 2006.\n\nCommenting on this announcement, Sareum's Chief Executive Officer, Dr Tim\nMitchell, said: \"This major collaboration with PIramed is a further endorsement\nof Sareum's leading position in structure-based drug discovery. We look forward\nto successfully using our multi-disciplinary platform to deliver drug candidates\nagainst these important disease targets.\"\n\n\n\nFor further information please contact:\n\n\nSareum Holdings +44 (0) 1223 497700\n\nTim Mitchell, Chief Executive Officer\n\n\nBuchanan Communications +44 (0) 20 7466 5000\n\nTim Anderson, Mary-Jane Johnson\n\n\n\n\nAbout Sareum Holdings plc\n\nSareum Holdings plc is a structure-based drug discovery business headquartered\nin Cambridge, UK. Sareum Limited was formed in August 2003 to discover new drugs\nfor the treatment of cancer and to provide a range of drug discovery services to\nthe pharmaceutical industry. Sareum's unique approach aims to halve the time it\n...